logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hyo S. Han

H. Lee Moffitt Cancer Center and Research Institute
H指数:37
被引数:5,057

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant therapy with an aromatase inhibitor and durvalumab in postmenopausal patients with hormone receptor-positive breast cancer

新辅助治疗：在绝经后激素受体阳性乳腺癌患者中使用芳香化酶抑制剂和 durvalumab。

Breast Cancer Research and Treatment
IF3
2026-02-160
PRE
Aixa E. Soyano Muller; Dawn N. Goodridge; Qianxing Mo; Junmin Whiting; Nazanin Khakpour; Marie Catherine Lee; Christine Laronga; Avan J. Armaghani; Hyo Han; Hatem Soliman; Ricardo Costa; Loretta Loftus; Susan J. Hoover; John V. Kiluk; Zena Jameel; Brian J. Czerniecki; Hung T. Khong
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report

Sacituzumab govitecan和立体定向放射手术治疗HER2阴性乳腺癌脑转移瘤：一项多中心报告

Journal of Neuro-Oncology
IF3.1
2025-09-300
PRE
Vaseem M. Khatri; Mariella A. Mestres-Villanueva; Sierra Daniel; Sreenija Yarlagadda; Ajay Doniparthi; Rituraj Upadhyay; Matthew N. Mills; Daniel E. Oliver; Hsiang-Hsuan Michael Yu; Joshua D. Palmer; Daniel G. Stover; Nicole O. Williams; Reshma L. Mahtani; Manmeet S. Ahluwalia; Aixa E. Soyano; Hatem H. Soliman; Hyo S. Han; Rupesh Kotecha; Sasha J. Beyer; Kamran A. Ahmed
Quantitative habitat concentration analysis of triple negative breast cancer on MRI correlates with pathologic response to combination neoadjuvant immuno/chemotherapy

MRI上三阴性乳腺癌的定量栖息地聚集分析与其对联合新辅助免疫/化疗的病理反应的相关性

CLINICAL IMAGING
IF1.5
2025-09-010
PRE
Weinfurtner, R. Jared; Ataya, Dana; Funaro, Kimberly; Bhatt, Asha; Abdalah, Mahmoud; Stringfield, Olya; Raghunand, Natarajan; Thompson, Zachary; Lee, Marie C.; Czerniecki, Brian; Muller, Aixa Soyano; Soliman, Hatem; Han, Hyo
Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy

激素受体阳性、HER2阴性晚期乳腺癌患者在接受gedatolisib联合palbociclib和内分泌治疗（一项评估gedatolisib的1b期临床试验）治疗后的总生存期

lancet oncology
IF0
2025-06-300
PRE
Rachel M Layman; Hyo S Han; Hope S Rugo; Erica M Stringer-Reasor; Jennifer M Specht; E Claire Dees; Peter Kabos; Samuel Suzuki; Sarah C Mutka; Brian F Sullivan; Igor Gorbatchevsky; Robert Wesolowski
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

NF1基因改变与CDK4/6抑制剂耐药在激素受体阳性转移性乳腺癌中的从临床到基础研究的转化分析

eBioMedicine
IF10.8
2025-06-270
PRE
Maxwell R. Lloyd; Rosario Chica-Parrado; Caroline M. Weipert; Todd C. Knepper; Emily L. Podany; Fabiana Napolitano; Dan Ye; Chang-Ching Lin; Yasuaki Uemoto; Jiemin Liao; Claire Wegrzyn; Christine M. Walko; Lianne Y. Ryan; Jennifer C. Keenan; Arielle J. Medford; Shiyuan A. Liu; Gerburg M. Wulf; Katherine K. Clifton; Cynthia X. Ma; Hyo S. Han; Nicole Zhang; Leif W. Ellisen; Aditya Bardia; Carlos L. Arteaga; Ariella B. Hanker; Seth A. Wander
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

Nivolumab和立体定向放射外科治疗乳腺癌脑转移患者：一项非随机、开放标签、Ib期研究的长期结果和生物标志物分析

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-04-280
OA
Ahmed, Kamran A.; Kim, Younchul; Kim, Sungjune; Wang, Min Hsuan; DeJesus, Michelle; Arrington, John A.; Soyano, Aixa E.; Armaghani, Avan J.; Costa, Ricardo L. B.; Loftus, Loretta S.; Rosa, Marilin; Caudell, Jimmy J.; Diaz, Roberto; Etame, Arnold B.; Tran, Nam D.; Soliman, Hatem; Czerniecki, Brian J.; Forsyth, Peter A.; Yu, Hsiang-Hsuan Michael; Han, Hyo S.
A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer

一项将HER2定向树突状细胞纳入早期HER2+ER-乳腺癌新辅助治疗的试点研究

NPJ BREAST CANCER
IF7.6
2025-03-170
OA
Soliman, Hatem; Aldrich, Amy; Abdo, Neveen; Han, Hyo; Soyano, Aixa; Costa, Ricardo; Armaghani, Avan; Kiluk, John; Khakpour, Nazanin; Lee, Marie Catherine; Hoover, Susan; Laronga, Christine; Niell, Bethany; Mooney, Blaise; Weinfurtner, Robert Jared; Rosa, Marilin; Czerniecki, Brian
Phase II trial of brain MRI surveillance in stage IV breast cancer

IV期乳腺癌中脑MRI监测的II期临床试验

NEURO-ONCOLOGY
IF13.4
2025-01-240
PRE
Ahmed, Kamran A.; Kim, Youngchul; Armaghani, Avan J.; Arrington, John A.; Costa, Ricardo L.; Czerniecki, Brian J.; Diaz, Roberto; Dowell, Robin A.; Extermann, Martine; Forsyth, Peter A.; Lee, Kimberley T.; Loftus, Loretta; Mills, Matthew N.; Phuoc, Vania H.; Rosa, Marilin; Soliman, Hatem H.; Sam, Christine S.; Washington, Iman R.; Soyano, Aixa E.; Han, Hyo S.
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer
BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-12-030
OAAI
Rugo, Hope S.; Campbell, Mike; Yau, Christina; Jo Chien, A.; Wallace, Anne M.; Isaacs, Claudine; Boughey, Judy C.; Han, Hyo S.; Buxton, Meredith; Clennell, Julia L.; Asare, Smita M.; Steeg, Katherine; Wilson, Amy; Singhrao, Ruby; Matthews, Jeffrey B.; Perlmutter, Jane; Fraser Symmans, W.; Hylton, Nola M.; Demichele, Angela M.; Yee, Douglas; Van't Veer, Laura J.; Berry, Donald A.; Esserman, Laura J.
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases
NPJ BREAST CANCER
IF7.6
2024-11-211
OA
Khatri, Vaseem M.; Mestres-Villanueva, Mariella A.; Yarlagadda, Sreenija; Doniparthi, Ajay; Smith, David B.; Nakashima, Justyn Y.; Bryant, John M.; Zhao, Dekuang; Upadhyay, Rituraj; Mills, Matthew N.; Oliver, Daniel E.; Yu, Hsiang-Hsuan Michael; Palmer, Joshua D.; Williams, Nicole O.; Mahtani, Reshma L.; Ahluwalia, Manmeet S.; Soliman, Hatem H.; Han, Hyo S.; Soyano, Aixa E.; Kim, Youngchul; Kotecha, Rupesh; Beyer, Sasha J.; Ahmed, Kamran A.
A bedside-to-bench translational analysis demonstrates that NF1 alterations promote CDK4/6 inhibitor (CDK4/6i) resistance in hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Lloyd, Maxwell; Chica-Parrado, M. Rosario; Knepper, Todd; Lin, Chang-Ching; Podany, Emily; Walko, Christine; Napolitano, Fabiana; Weipert, Caroline; Liao, Jiemin; Medford, Arielle; Ryan, Lianne; Keenan, Jennifer; Zhang, Nicole; Liu, Shiyuan; Wulf, Gerburg; Clifton, Katherine; Ma, Cynthia; Han, Hyo; Ellisen, Leif; Bardia, Aditya; Arteaga, Carlos; Hanker, Ariella; Wander, Seth
Updated results from VERITAC evaluating vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, in ER- positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer

VERITAC评估ER阳性/人表皮生长因子受体2 (HER2) 阴性晚期乳腺癌中蛋白水解靶向嵌合体 (PROTAC) 雌激素受体 (ER) 降解剂vepdegestrant的更新结果

CANCER RESEARCH
IF16.6
2024-05-021
PRE
Hurvitz, Sara; Schott, Anne; Ma, Cynthia; Nanda, Rita; Zahrah, George; Hunter, Natasha; Tan, Antoinette; Telli, Melinda; Mesias, Jesus Anampa; Jeselsohn, Rinath; Munster, Pamela; Zhi, Eric; Duperret, Elizabeth; Mather, Cecile; Hamilton, Erika; Han, Hyo
Immune subtyping identifies a subset of HR+HER2-early-stage breast cancer patients with a very high likelihood of response to neoadjuvant immunotherapy (IO): Results from 5 IO arms of the I-SPY2 TRIAL
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Wolf, Denise M.; Yau, Christina; Pusztai, Lajos; Nanda, Rita; Chien, Jo; Stringer-Reasor, Erica; Shatsky, Rebecca; Isaacs, Claudine; Liu, MInetta; Han, Hyo; Soliman, Hatem; Campbell, Michael; Glas, Annuska; Barcaru, Andrei; Mittempergher, Lorenza; Kuilman, Midas; Swigart, Lamorna Brown; Hirst, Gillian; Yu, Hongmei; Beineke, Philip; Basu, Amrita; Yee, Douglas; Symmans, W. Fraser; DeMichele, Angela; Perlmutter, Jane; Delson, Amy; Huppert, Laura; Rugo, Hope; Clark, Amy; Hylton, Nola; Pohlmann, Paula; Esserman, Laura; van 't Veer, Laura
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial

Veliparib联合卡铂和紫杉醇治疗BRCA突变的晚期乳腺癌 (BROCADE3): 一项随机3期试验的最终总生存期结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-03-014
PRE
Dieras, Veronique; Hanc, Hyo S.; Wildiers, Hans; Friedlander, Michael; Ayoub, Jean- Pierre; Puhalla, Shannon L.; Loirat, Delphine; Ratajczak, Christine; Adamu, Hephzibah; Girardi, Vincent; Arun, Banu K.

研究方向

暂未获取到该数据
H
Hatem Soliman
H 指数:45论文数:278被引数:1.2万
B
Brian J. Czerniecki
H 指数:57论文数:373被引数:1.1万
K
Kamran A. Ahmed
H 指数:37论文数:275被引数:4,553
P
Peter Forsyth
H 指数:81论文数:471被引数:2.4万
A
Aixa Soyano
H 指数:12论文数:78被引数:1,542
R
Ricardo Costa
H 指数:25论文数:147被引数:3,223
A
Avan Armaghani
H 指数:9论文数:53被引数:326
E
Erika Hamilton
H 指数:58论文数:843被引数:1.6万
R
Rita Nanda
H 指数:56论文数:548被引数:1.6万
A
Arnold B. Etame
H 指数:34论文数:178被引数:4,436